Solvay SA : The calm spell can be taken advantage of to put on new positions
BUY
Conditionne
Stop-loss triggered
Entry price | Target | Stop-loss | Potential |
---|
€118.4 |
€126 |
€115 |
+6.42% |
---|
An exit from the recently observed accumulation phase to the upside could allow for the assumption that a clear upward trend is re-established with an increase in volatility.
Summary● The company has solid fundamentals for a short-term investment strategy.
Strengths● The close medium term support offers good timing for purchasing the stock.
● Historically, the company has been releasing figures that are above expectations.
● The company's attractive earnings multiples are brought to light by a P/E ratio at 14.19 for the current year.
● Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
Weaknesses● As estimated by analysts, this group is among those businesses with the lowest growth prospects.
● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
● The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.